30. Chromosomal microarray analysis work-up for hypocellular MDS patients with inconclusive cytogenetics

Identification of chromosomal abnormalities is essential for diagnosis, prognosis, and therapeutic decision-making in myelodysplastic neoplasms (MDS). Hypocellular MDS (h-MDS), is a newly recognized diagnostic sub-entity under the 2022 WHO classification (

Source: Cancer Genetics and Cytogenetics - November 1, 2023 Category: Genetics & Stem Cells Authors: Ha Nguyen, Fangling Xu, Sherin Raju, Nazneen Ahmed, Christopher Bowman, Hector Alvarez, Hyvan Dang, Awdhesh Kalia, Peter Hu, Rajyalakshmi Luthra, Diana Rush, Guilin Tang, Kunhwa Kim, Kelly Chien, Guillermo Garcia-Manero Source Type: research